Gene transfer strategies for improving radiolabeled peptide imaging and therapy

Quarterly Journal of Nuclear Medicine

Volumn 44, Issue 3, 2000, Pages 208-223

  Rogers, B E ^a   Zinn, K R ^a   Buchsbaum, D J ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

Gene transfer; Genetic Vectors; Neoplasms radionuclide imaging; Neoplasms radiotherapy; Receptors, somatostatin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; DOPAMINE 2 RECEPTOR; LIPOFECTIN; OCTREOTIDE; PEPTIDE DERIVATIVE; RADIOLIGAND; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ADENOVIRUS; CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CLONING VECTOR; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC MARKER; HUMAN; IN VIVO STUDY; MOLECULAR BIOLOGY; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; RECEPTOR GENE; REVIEW;

ADENOVIRIDAE; ANIMAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMAN; NEOPLASMS; PEPTIDES; RADIOPHARMACEUTICALS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033793301     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. Molecular biology in cancer medicine
2. 99 mTc annexin V
3. Phage display of combinatorial peptide and protein libraries and their applications in biology and chemistry
4. Polypeptides from phage display. A superior source of in vivo imaging agents
5. Vascular targeting with phage peptide libraries
6. Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu
7. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas
8. Production and characterization of an anti-(MUC1 mucin) recombinant diabody
9. Noninfectious gene transfer and expression systems for cancer gene therapy
10. Gene therapy for cancer: What have we done and where are we going?
11. Therapeutic gene targeting
12. Cancer gene therapy: Connecting basic research with clinical inquiry
13. Viral vectors for gene therapy
14. Gene therapy: A primer for radiologists
15. Human gene marker/therapy clinical protocols
16. Approaches to enhance cancer radiotherapy employing gene transfer methods
17. Genetic induction of antigens and receptors as targets for cancer radiotherapy
18. Targeting strategies for cancer radiotherapy
19. The role of radiolabeled somatostatin analogs in the management of cancer patients
20. 86Y-DTPA-octreotide
21. 188Re-RC-160
22. 90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours
23. 99mTc-P829
24. The utility of a somatostatin-type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules
25. 3-Octreotide: Preliminary report in cancer patients
26. 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: Evaluation of new derivatives for positron emission tomography imaging and targeted radiotherapy
27. 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake
28. High purity production and potential applications of copper-60 and copper-61
29. 67Ga scintigraphy in malignant lymphoma
30. 213BiDOTATOC) for peptide receptor radionuclide therapy (PRRT)
31. 213Bi-DOTATOC) in peptide receptor radionuclide therapy (PRRT)
32. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
33. Molecular genetics
34. Nucleic acid amplification technologies
35. Gene gun and other non-viral approaches for cancer gene therapy
36. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
37. Adeno-associated viral vectors for gene transfer and gene therapy
38. Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus
39. Cationic liposome-mediated gene transfer
40. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration
41. Molecular biology of cell nonpermissiveness to retroviruses. Has the time come?
42. Retrovirus-mediated gene transfer into human hematopoietic stem cells
43. In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors
44. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
45. A simplified system for generating recombinant adenoviruses
46. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene
47. Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin releasing peptide receptor by an adenoviral vector
48. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer
49. Adenoviral mediated delivery of gastrin releasing peptide receptor results in specific tumor localization of a bombesin analogue in vivo
50. 2 receptor as a reporter gene in living animals
51. Assays for noninvasive imaging of reporter gene expression
52. 1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector
53. 188Re
54. Imaging the expression of transfected genes in vivo
55. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
56. In vivo imaging of gene expression associated with cell replication
57. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography
58. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir
59. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo
60. Herpes simplex virus thymidine kinase as a marker reporter gene for PET imaging of gene therapy
61. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
62. MR imaging and scintigraphy of gene expression through melanin induction
63. Tumor induction of VEGF promoter activity in stromal cells
64. Measuring transferrin receptor gene expression by NMR imaging
65. Bioluminescent indicators in living mammals
66. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
67. Molecular imaging: Exploring the next frontier
68. Imaging adenoviral-mediated gene transfer of gastrin releasing peptide receptor (GRPr) using a Tc-99m-labeled bombesin (BBN) analogue
69. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides
70. Somatostatin receptor-binding peptides labeled with technetium-99m: Chemistry and initial biological studies
71. Tumor regression in rat pancreatic (AR42J) tumor-bearing mice with Re-188 P2045 - A somatostatin analog
72. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
73. Antineoplastic 'multimodality adenovirus' containing E1A and a therapeutic transgene
74. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase
75. A mutant oncolytic adenovirus targeting in the Rb pathway in brain tumors
76. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo
77. The role of the bystander effect in suicide gene therapy
78. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy
79. Cancer chemotherapy using suicide genes
80. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer
81. Enhanced in vivo gene delivery to human ovarian cancer xenografts utilizing a tropism-modified adenovirus vector
82. Addition of a short peptide ligand to the adenovirus fiber protein
83. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs
84. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
85. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
86. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
87. Characterization of an adenoviral vector containing a heterologous peptide epitope in the HI-loop of the fiber knob
88. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
89. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae
90. Gene therapy of prostate cancer: p53, suicidal genes, and other targets
91. Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen
92. Gene therapy of gliomas: Receptor and transcriptional targeting
93. Basic science of HER-2/neu: A review